EFTX-G12V:KRASG12VRNAi

Kostas A Papavassiliou1, Alice G Vassiliou2, Athanasios G Papavassiliou3

  • 1First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.

概括

斯坦兰和同事开发了EFTX-G12V,一种新的小干扰RNA (siRNA) 疗法. 这种疗法选择性地使KRASG12V沉默,导致瘤回归,并为以前无法治疗的癌症提供了一种新策略.